Obesity II: Establishing causal links between chemical exposures and obesity - Université Paris Cité Accéder directement au contenu
Article Dans Une Revue Biochemical Pharmacology Année : 2022

Obesity II: Establishing causal links between chemical exposures and obesity

Mathew K Kay
  • Fonction : Auteur

Résumé

Obesity is a multifactorial disease with both genetic and environmental components. The prevailing view is that obesity results from an imbalance between energy intake and expenditure caused by overeating and insufficient exercise. We describe another environmental element that can alter the balance between energy intake and energy expenditure: obesogens. Obesogens are a subset of environmental chemicals that act as endocrine disruptors affecting metabolic endpoints. The obesogen hypothesis posits that exposure to endocrine disruptors and other chemicals can alter the development and function of the adipose tissue, liver, pancreas, gastrointestinal tract, and brain, thus changing the set point for control of metabolism. Obesogens can determine how much food is needed to maintain homeostasis and thereby increase the susceptibility to obesity. The most sensitive time for obesogen action is in utero and early childhood, in part via epigenetic programming that can be transmitted to future generations. This review explores the evidence supporting the obesogen hypothesis and highlights knowledge gaps that have prevented widespread acceptance as a contributor to the obesity pandemic. Critically, the obesogen hypothesis changes the narrative from curing obesity to preventing obesity.
Fichier principal
Vignette du fichier
Heindel et al-2022-Obesity II.pdf (1.84 Mo) Télécharger le fichier
Corrigendum.pdf (492.11 Ko) Télécharger le fichier
Origine : Fichiers produits par l'(les) auteur(s)

Dates et versions

hal-03705630 , version 1 (05-08-2022)

Identifiants

Citer

Jerrold J Heindel, Sarah Howard, Keren Agay-Shay, Juan P Arrebola, Karine Audouze, et al.. Obesity II: Establishing causal links between chemical exposures and obesity. Biochemical Pharmacology, 2022, 199, pp.115015. ⟨10.1016/j.bcp.2022.115015⟩. ⟨hal-03705630⟩
396 Consultations
321 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More